BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27093554)

  • 1. Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes.
    Brim S; Groschup MH; Kuczius T
    PLoS One; 2016; 11(4):e0153931. PubMed ID: 27093554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metal binding on solubility and resistance of physiological prions depend on tissues and glycotypes.
    Kuczius T; Kelsch R
    J Cell Biochem; 2013 Dec; 114(12):2690-8. PubMed ID: 23794222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein.
    Leach SP; Salman MD; Hamar D
    Anim Health Res Rev; 2006; 7(1-2):97-105. PubMed ID: 17389057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
    Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
    PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular prion proteins in humans and cattle but not sheep are characterized by a low-solubility phenotype.
    Kuczius T; Groschup MH
    Comp Immunol Microbiol Infect Dis; 2013 Dec; 36(6):599-605. PubMed ID: 23948376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain-specific prion-protein conformation determined by metal ions.
    Wadsworth JD; Hill AF; Joiner S; Jackson GS; Clarke AR; Collinge J
    Nat Cell Biol; 1999 May; 1(1):55-9. PubMed ID: 10559865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC).
    Müller H; Strom A; Hunsmann G; Stuke AW
    Biochem J; 2005 May; 388(Pt 1):371-8. PubMed ID: 15658935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region.
    Perera WS; Hooper NM
    Curr Biol; 2001 Apr; 11(7):519-23. PubMed ID: 11413003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The functional links between prion protein and copper.
    Varela-Nallar L; Toledo EM; Chacón MA; Inestrosa NC
    Biol Res; 2006; 39(1):39-44. PubMed ID: 16629163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi.
    Brown LR; Harris DA
    J Neurochem; 2003 Oct; 87(2):353-63. PubMed ID: 14511113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prion paradox: infection or polymerisation?
    Biro JC
    Appl Bioinformatics; 2003; 2(3 Suppl):S25-30. PubMed ID: 15130813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional heterogeneity of cellular prion protein isoforms in the mouse brain.
    Beringue V; Mallinson G; Kaisar M; Tayebi M; Sattar Z; Jackson G; Anstee D; Collinge J; Hawke S
    Brain; 2003 Sep; 126(Pt 9):2065-73. PubMed ID: 12821516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A receptor for infectious and cellular prion protein.
    Martins VR
    Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallic prions.
    Brown DR
    Biochem Soc Symp; 2004; (71):193-202. PubMed ID: 15777022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular prion protein: biochemistry, topology, and physiologic functions.
    Griffoni C; Toni M; Spisni E; Bianco M; Santi S; Riccio M; Tomasi V
    Cell Biochem Biophys; 2003; 38(3):287-304. PubMed ID: 12794269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
    Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
    PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.